Kissei Pharmaceutical (4547.T) Earnings Analysis
Kissei Pharmaceutical (4547.T) next reports earnings on 2026-07-31, consensus EPS 64.09 JPY. Last quarter (2026-05-11) it missed with EPS 66.77 JPY vs 81.93 JPY est (-18.5%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 12.74.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4547.T next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 64.09 JPY |
| Revenue estimate | 22.23B |
4547.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 66.77 JPY | 81.93 JPY | -18.5% | Miss |
| 2026-01-30 | 77.96 JPY | -38.49653 JPY | +302.5% | Beat |
| 2025-02-03 | 82.65 JPY | 85.02 JPY | -2.8% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
4547.T valuation and analyst view
| Trailing P/E | 12.74 |
|---|---|
| Trailing EPS | 332.67 JPY |
| Price / book | 0.76 |
| Dividend yield | 3.79% |
| Market cap | 173.68B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Kissei Pharmaceutical (4547.T)'s next earnings date?
Kissei Pharmaceutical is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 64.09 JPY and revenue estimate of 22.23B.
Did 4547.T beat earnings last quarter?
In its 2026-05-11 report, 4547.T posted EPS of 66.77 JPY versus a 81.93 JPY estimate — a miss of 18.5%.
What is 4547.T's earnings track record?
Over the last 3 reported quarters with consensus data, 4547.T beat estimates 1 times (33%).
What is 4547.T's current P/E ratio and EPS?
4547.T trades at a trailing P/E of 12.74 on trailing EPS of 332.6653306613226 JPY.
What do analysts rate 4547.T?
4547.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.